Analyze how specific documents activate the features of the SAE. Select a dataset, a run and a document to begin.
1503
Details List
Document Content
Neuroprotective properties of aucubin in diabetic rats and diabetic encephalopathy rats.
In this study, we determined the neuroprotective effect of aucubin on diabetes and diabetic encephalopathy. With the exception of the control group, all rats received intraperitoneal injections of streptozotocin (STZ; 60 mg/kg) to induce type 1 diabetes mellitus (DM). Aucubin (1, 5, 10 mg/kg ip) was used after induction of DM (immediately) and diabetic encephalopathy (65 days after the induction of diabetes). The diabetic encephalopathy treatment groups were divided into short-term and long-term treatment groups. Treatment responses to all parameters were examined (body weight, plasma glucose, Y-maze error rates and proportion of apoptotic cells). In diabetic rats, aucubin controlled blood glucose levels effectively, prevented complications, and improved the quality of life of diabetic rats. In diabetic encephalopathy, aucubin significantly rescued neurons in the hippocampal CA1 subfield and reduced working errors during behavioral testing. The significant neuroprotective effect of aucubin could be seen not only in the short term (15 days) but also in the long term (45 days), which was a highly encouraging finding. These data suggest that aucubin may be a potential neuroprotective agent.
Similar Documents
-
#453 0.503Type II Diabetes Mellitus Accelerates Age-Depende…
-
#149 0.444Catechin-loaded Eudragit microparticles for the m…
-
#443 0.438Can marked hyperglycemia occur without ketosis? T…
-
#382 0.436Inhibition of glutamine synthetase in rabbit pneu…
-
#869 0.427Insulin induced reversibility of altered responsi…